CON: Therapy for a Patient with Platinum–Resistant/Refractory Ovarian Cancer Should Not Be Selected Based on Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay

✍ Scribed by John Farley; Michael J. Birrer

• Book ID: 119645772
• Publisher: CIG Media Group, LP.
• Year: 2008
• Tongue: English
• Weight: 342 KB
• Volume: 1
• Category: Article
• ISSN: 1941-4390
• DOI: 10.1016/s1941-4390(11)70048-4